Can You Take Alprazolam and Alcohol Together?

Combining alprazolam (Xanax) with alcohol is extremely dangerous and potentially fatal — both substances depress the central nervous system by enhancing GABA activity, and their combined effect is multiplicative rather than simply additive. Together, they can suppress respiratory drive to the point of respiratory arrest, cause profound sedation and loss of consciousness, and dramatically increase the risk of overdose death. This combination is one of the most common causes of benzodiazepine-related overdose deaths, many of which occur in people who are prescribed alprazolam and drink alcohol, often without realizing the severity of the risk.

People mix alprazolam and alcohol for several reasons: both produce anxiolytic (anxiety-reducing) and sedating effects that can feel complementary; people may not fully understand the severity of the interaction; tolerance may develop separately to each substance, creating a false sense of safety; and both substances can impair the judgment needed to recognize and respond to dangerous levels of sedation. For women with anxiety disorders who are prescribed alprazolam and also drink, this combination is particularly dangerous because it creates a pattern of dual CNS depressant use that escalates over time as tolerance develops to each substance.

When alprazolam and alcohol are combined, both substances bind to GABA receptors in the brain and throughout the nervous system, producing synergistic CNS depression that goes far beyond what either substance alone would cause. Effects include extreme sedation, significantly impaired coordination and judgment, slowed or stopped breathing (the most dangerous effect), lowered blood pressure, memory blackouts, and loss of consciousness. The respiratory depression risk is particularly dangerous during sleep, when early warning signs are not perceived and the person cannot respond to distress.

Yes — the combination of alprazolam and alcohol can and does cause death, and this drug combination is implicated in a significant proportion of overdose fatalities involving benzodiazepines. Many of these deaths occur in people with legitimate prescriptions who drink socially, not realizing that even moderate alcohol consumption significantly amplifies the respiratory depressant effects of their prescribed medication. For women with alcohol use disorder who are also prescribed alprazolam, the risk is even more severe because the amounts of alcohol consumed may be significantly higher than social drinking levels.

The medical consensus is that alcohol should be avoided entirely while taking alprazolam — there is no established safe level of alcohol consumption that can be combined with alprazolam without elevating overdose risk. Even one to two drinks with a typical therapeutic dose of alprazolam can produce sedation and coordination impairment significantly beyond either substance alone. For women who are prescribed alprazolam and also drink, this is an important conversation to have directly and honestly with the prescribing physician.

If someone has taken alprazolam and alcohol together and is showing signs of severe CNS depression — extreme sedation, slow or shallow breathing, inability to be awakened, bluish lips or fingernails — call 911 immediately. This is a medical emergency. While waiting for emergency services, keep the person on their side to prevent aspiration if they vomit, monitor breathing, and do not leave them alone. Flumazenil can reverse benzodiazepine effects in some circumstances but is not universally used due to its own risks; naloxone does not reverse benzodiazepine overdose. Time is critical in this situation.

Co-dependence on both benzodiazepines (including alprazolam) and alcohol is relatively common, particularly in women who were initially prescribed alprazolam for anxiety and who also drink to manage anxiety — creating parallel CNS depressant dependencies that are mutually reinforcing. The combination is particularly insidious because both substances appear to address the same problem (anxiety) while actually worsening the underlying anxiety disorder over time. Women with co-occurring anxiety disorder and alcohol use disorder are at elevated risk of this pattern, and it requires careful, medically supervised treatment to address both dependences safely.

Benzodiazepine dependence, including alprazolam dependence, requires medically supervised withdrawal because abrupt cessation of benzodiazepines — like alcohol — can cause life-threatening seizures. A slow, carefully managed taper under medical supervision is the standard approach, and the timeline for benzodiazepine tapering is typically much longer than for alcohol detox — often weeks to months for severe dependence. For women with co-occurring alprazolam and alcohol dependence, the withdrawal management is particularly complex and requires close medical oversight. Pioneer Recovery Center coordinates with medical detox providers to ensure safe management before residential admission.

Benzodiazepine withdrawal is typically managed by gradually tapering the benzodiazepine itself (often switching to a longer-acting formulation like diazepam to allow for a smoother taper), sometimes supplemented with anticonvulsants like carbamazepine or valproate to reduce seizure risk. The specific protocol depends on the severity of dependence, the specific benzodiazepine involved, and individual medical factors — which is why medical supervision is essential. Attempting to taper off alprazolam without medical guidance is dangerous and frequently unsuccessful.

Yes — recovery from dual dependence on alprazolam and alcohol is absolutely achievable with appropriate medical and clinical support. The recovery process involves medically supervised withdrawal management, treatment of the underlying anxiety disorder that drove benzodiazepine use (often with non-addictive medications and evidence-based therapies like CBT), comprehensive addiction treatment for the alcohol use disorder, and long-term recovery support. Pioneer Recovery Center serves women with polysubstance use disorders including benzodiazepine dependence, and our individualized assessment ensures that each woman's complete clinical picture — including all substances involved — shapes her treatment plan.